CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | Hung David Director | Grant or award | +11,610 | 32,075 | ||
| 2026-06-03 | Hung David Director | Grant or award · Stock Option (Right to Buy) | +16,999 | 16,999 | ||
| 2026-06-02 | Hung David Director | Sale | −2,945 | $15.77 | $46K | 20,465 |
| 2025-06-04 | Hung David Director | Grant or award | +11,215 | 23,410 | ||
| 2025-06-04 | Hung David Director | Grant or award · Stock Option (Right to Buy) | +16,697 | 16,697 | ||
| 2025-06-03 | Hung David Director | Sale | −999 | $17.30 | $17K | 12,195 |
| 2024-06-05 | Hung David Director | Grant or award | +4,053 | 13,194 | ||
| 2024-06-05 | Hung David Director | Grant or award · Stock Option (Right to Buy) | +6,229 | 6,229 | ||
| 2023-06-07 | Hung David Director | Grant or award · Stock Option (Right to Buy) | +12,554 | 12,554 |
Page 1 of 1 · 9 trades